부산대학교 도서관

Kotagiri, P; Rae, WM; Bergamaschi, L; Pombal, D; Lee, J; Noor, NM; Sojwal, RS; Rubin, SJS; Unger, LW; Tolmeijer, SH; Manferrari, G; Bashford-Rogers, RJM; Bingham, DB; Stift, A; Rogalla, S; Gubatan, J; Lee, JC; Smith, KGC; McKinney, EF; Boyd, SD; Lyons, PA

Nat Commun
Nature Communications, Vol 16, Iss 1, Pp 1-13 (2025)

Pamidimarri Naga S; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Slootbeek PHJ; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Gillissen C; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Ligtenberg MJL; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; de Voer RM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101708809 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-4276 (Electronic) Linking ISSN: 24734276 NLM ISO Abbreviation: JCO Clin Cancer Inform Subsets: MEDLINE

Kloots ISH; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; Slootbeek PHJ; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; Tolmeijer SH; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; van Wilpe S; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; Smits M; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; van Helvert S; Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands.; Kroeze LI; Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands.; van Ipenburg JA; Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands.; Grünberg K; Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands.; Kets CM; Department of Human Genetics, Radboud university medical centre, Nijmegen, The Netherlands.; Ligtenberg MJL; Department of Pathology, Radboud university medical centre, Nijmegen, The Netherlands.; Department of Human Genetics, Radboud university medical centre, Nijmegen, The Netherlands.; Nagarajah J; Department of Medical Imaging, Radboud university medical centre, Nijmegen, The Netherlands.; Fütterer J; Department of Medical Imaging, Radboud university medical centre, Nijmegen, The Netherlands.; van Dodewaard JM; Department of Medical Oncology, Meander medical centre, Amersfoort, The Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, The Netherlands.; Terheggen F; Department of Medical Oncology, Bravis Ziekenhuis, Roosendaal, The Netherlands.; Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.; Schalken JA; Department of Urology, Radboud university medical centre, Nijmegen, the Netherlands.; van Oort IM; Department of Urology, Radboud university medical centre, Nijmegen, the Netherlands.; Department of Urology, University Medical Centre Groningen, Groningen, the Netherlands.; Bloemendal HJ; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud university medical centre, Nijmegen, The Netherlands. niven.mehra@radboudumc.nl.

Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

Virtanen T; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Eastern Health Clinical School, Monash University, Melbourne, Australia.; Parekh K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Bacon JVW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Huang CF; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Yu IPL; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Ryyppö L; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Bernales CQ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Tam C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Sipola J; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Nikkola J; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Vandekerkhove G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Kukkonen K; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Adelia; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Eigl BJ; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Finch D; BC Cancer - Cancer Centre for the Southern Interior, Kelowna, Canada.; Gagnon R; Tom Baker Cancer Centre, Calgary, Canada.; Takieldeen Y; Department of Radiology and Imaging Sciences, Indiana University School of Medicine, Indiana, USA.; Hardy E; BC Cancer - Vernon Cancer Centre, Vernon, Canada.; Khalaf D; Sunnybrook Health Sciences Centre, Toronto, Canada.; Kollmannsberger C; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Lavoie JM; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Maurice-Dror C; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Miller S; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Nappi L; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Noonan K; BC Cancer - Surrey Cancer Centre, Surrey, Canada.; Parimi S; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Riminchan A; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Sartori-Mueller E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Soleimani M; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Vergidis J; BC Cancer - Victoria Cancer Centre, Victoria, Canada.; Zulfiqar M; BC Cancer - Abbotsford Cancer Centre, Abbotsford, Canada.; Hansen A; Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.; Hotte S; Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Canada.; Jafri M; Canadian Cancer Trials Group, Queen's University, Kingston, Canada.; Kolinsky M; Cross Cancer Institute, Edmonton, Canada.; Mukherjee SD; Department of Oncology, McMaster University, Hamilton, Canada.; Ong M; Ottawa Hospital Research Institute, Ottawa, Canada.; Rose AAN; Segal Cancer Center, Jewish General Hospital & McGill University, Montreal, Canada.; Tu W; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada.; Winquist E; Verspeeten Family Cancer Centre at London Health Sciences Centre, London, Canada.; Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Canada.; van der Zande K; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Canada.; Zwart W; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Canada; Oncode Institute, Utrecht, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van Erp NP; Department of Pharmacy, Pharmacology and Toxicology, Radboud University Medical Center, Nijmegen, The Netherlands.; Zhao JL; Department of SystImmune Inc, Redmond, USA.; Rathkopf D; Department of Memorial Sloan-Kettering Cancer Center, New York, USA; Department of Weill Cornell Medical College, New York, USA.; Barbieri CE; Department of Urology, Weill Cornell Medicine, New York, USA.; Quigley DA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF), San Francisco, USA; Department of Epidemiology and Biostatistics, UCSF, San Francisco, USA.; Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Lack NA; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Medical Pharmacology, School of Medicine, Koç University, Istanbul, Turkey.; Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; BC Cancer - Vancouver Cancer Centre, Vancouver, Canada.; Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland. Electronic address: matti.annala@tuni.fi.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada; Department of Basic and Translational Research, BC Cancer Research Institute, Vancouver, Canada. Electronic address: alexander.wyatt@ubc.ca.

Publisher: Elsevier Country of Publication: England NLM ID: 9007735 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1569-8041 (Electronic) Linking ISSN: 09237534 NLM ISO Abbreviation: Ann Oncol Subsets: MEDLINE

Parekh K; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; van der Zande K; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ng SWS; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; Herberts C; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; Kwan EM; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada; Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC, Australia.; Vandekerkhove G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; van der Noort V; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Busard MPH; Department of Radiology and Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.; van den Berg P; Department of Medical Oncology, Tergooi, Hilversum, The Netherlands.; de Feijter JM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Dezentje V; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hamberg P; Department of Medical Oncology, Vlietland Gasthuis, Schiedam, The Netherlands.; Houtsma D; Department of Internal Medicine, Haga Hospital, The Hague, The Netherlands.; Ras S; Department of Medical Oncology, Vlietland Gasthuis, Schiedam, The Netherlands.; Tascilar M; Department of Medical Oncology, Isala, Zwolle, The Netherlands.; Tutuhatunewa-Louhanepessy RD; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ruby Liao YJ; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; Tolmeijer SH; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; Donnellan G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada.; Chi KN; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada; Department of Medical Oncology, BC Cancer, Vancouver, British Columbia, Canada.; Wyatt AW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, BC, Canada; Clinical Cancer Genomics Program and Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada. Electronic address: awyatt@prostatecentre.com.; Zwart W; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands; Oncode Institute, Utrecht, The Netherlands. Electronic address: w.zwart@nki.nl.; Bergman AM; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Oncogenomics, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, The Netherlands. Electronic address: a.bergman@nki.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.; Biomedicine Discovery Institute Cancer Program, Prostate Cancer Research Group, Department of Anatomy and Developmental Biology, Monash University, Melbourne, Victoria, Australia.; Ng SWS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Emmett L; Department of Theranostics and Nuclear Medicine, St Vincent's Hospital, Sydney, New South Wales, Australia.; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Sandhu S; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Buteau JP; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Iravani A; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Division of Nuclear Medicine, Department of Radiology, University of Washington School of Medicine, Seattle, WA, USA.; Fred Hutchinson Cancer Center, Seattle, WA, USA.; Joshua AM; School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.; Garvan Institute of Medical Research, Sydney, New South Wales, Australia.; Department of Medical Oncology, Kinghorn Cancer Centre, Sydney, New South Wales, Australia.; Francis RJ; Department of Nuclear Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.; Medical School, University of Western Australia, Perth, Western Australia, Australia.; Subhash V; Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Sydney, New South Wales, Australia.; Lee ST; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; Scott AM; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, Victoria, Australia.; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Melbourne, Victoria, Australia.; Martin AJ; NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.; Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia.; Stockler MR; Centre for Clinical Research, University of Queensland, Brisbane, Queensland, Australia.; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.; Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Annala M; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere, Finland.; Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Davis ID; Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia. ian.davis@monash.edu.; Cancer Services, Eastern Health, Melbourne, Victoria, Australia. ian.davis@monash.edu.; Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. michael.hofman@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. michael.hofman@petermac.org.; Azad AA; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. arun.azad@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia. arun.azad@petermac.org.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada. alexander.wyatt@ubc.ca.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada. alexander.wyatt@ubc.ca.

Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

Slootbeek PHJ; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.; Tolmeijer SH; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.; Mehra N; Department of Medical Oncology, Radboud university medical center, Nijmegen, The Netherland.; Schalken JA; Department of Experimental Urology, Research Institute of Medical Innovation, Radboud university medical center, Nijmegen, The Netherlands.

Publisher: Informa Healthcare Country of Publication: England NLM ID: 8914816 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-781X (Electronic) Linking ISSN: 10408363 NLM ISO Abbreviation: Crit Rev Clin Lab Sci Subsets: MEDLINE

Fonseca NM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Maurice-Dror C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Tu W; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Fan W; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Murtha AJ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Kollmannsberger C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Department of Medicine, School of Clinical Sciences; Monash University, Melbourne, VIC, Australia.; Parekh K; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Schönlau E; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Bernales CQ; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Ng SWS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Sumiyoshi T; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Urology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.; Vergidis J; Department of Medical Oncology, BC Cancer, Victoria, BC, Canada.; Noonan K; Department of Medical Oncology, BC Cancer, Surrey, BC, Canada.; Finch DL; Department of Medical Oncology, BC Cancer, Kelowna, BC, Canada.; Zulfiqar M; Department of Medical Oncology, BC Cancer, Abbotsford, BC, Canada.; Miller S; Department of Radiation Oncology, BC Cancer, Prince George, BC, Canada.; Parimi S; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Lavoie JM; Department of Medical Oncology, BC Cancer, Victoria, BC, Canada.; Hardy E; Tom McMurtry & Peter Baerg Cancer Centre, Vernon Jubilee Hospital, Vernon, BC, Canada.; Soleimani M; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Nappi L; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Eigl BJ; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Kollmannsberger C; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Taavitsainen S; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada.; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University, Nijmegen, The Netherlands.; Boerrigter E; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University, Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University, Nijmegen, The Netherlands.; van Erp NP; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University, Nijmegen, The Netherlands.; De Laere B; Department of Human Structure and Repair, Ghent University, Ghent, Belgium.; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.; Lindberg J; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.; Grönberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.; Khalaf DJ; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.; Annala M; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. matti.annala@tuni.fi.; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland. matti.annala@tuni.fi.; Chi KN; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. kchi@bccancer.bc.ca.; Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada. kchi@bccancer.bc.ca.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada. awwyatt@mail.ubc.ca.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, BC, Canada. awwyatt@mail.ubc.ca.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

van Wilpe S; Medical Oncology Department, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Croci D; Novigenix SA, Epalinges, Switzerland.; Fonseca Costa SS; Novigenix SA, Epalinges, Switzerland.; Te Paske IB; Medical Oncology Department, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Tolmeijer SH; Medical Oncology Department, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; van Ipenburg J; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Kroeze LI; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Pavan S; Novigenix SA, Epalinges, Switzerland.; Monnier-Benoit S; Novigenix SA, Epalinges, Switzerland.; Coccia G; Novigenix SA, Epalinges, Switzerland.; Hadadi N; Novigenix SA, Epalinges, Switzerland.; Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, Netherlands.; Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, Netherlands.; van Voorthuizen T; Department of Medical Oncology, Rijnstate, Arnhem, Netherlands.; Berends M; Department of Medical Oncology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands.; Franken MD; Medical Oncology Department, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Ligtenberg MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.; Hosseinian Ehrensberger S; Novigenix SA, Epalinges, Switzerland.; Ciarloni L; Novigenix SA, Epalinges, Switzerland.; Romero P; Novigenix SA, Epalinges, Switzerland.; Mehra N; Medical Oncology Department, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, Netherlands.

Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE

Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre and Clinical Cancer Genomics Program, BC Cancer, Vancouver, British Columbia, Canada.; Litiere S; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Bidard FC; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France.; Cabel L; Department of Medical Oncology, Institut Curie, Université Versailles Saint-Quentin, Université Paris-Saclay, Saint-Cloud, France.; Dyrskjøt L; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Karlovich CA; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Pantel K; Department of Tumor Biology, Center for Experimental Medicine, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Petrie J; Canadian Cancer Trials Group, Kingston, Ontario, Canada.; Philip R; Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, Maryland.; Andrews HS; Friends of Cancer Research, Washington, District of Columbia.; Vellanki PJ; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.; Tolmeijer SH; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Villalobos Alberu X; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; Alfano C; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Bogaerts J; European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium.; Calvo E; START Madrid-CIOCC, Centro Integral Oncológico Clara Campal, Madrid, Spain.; Chen AP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Toledo RA; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.; de Vries EGE; University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands.; Seymour L; Canadian Cancer Trials Group, Queen's University, Kingston, Ontario, Canada.; Laurie SA; Division of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada.; Garralda E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Tolmeijer SH; Boerrigter E; Van Erp NP; Mehra N

Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Electronic Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; van Wilpe S; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Geerlings MJ; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; von Rhein D; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Smilde TJ; Department of Medical Oncology, Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands.; Kloots ISH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Westdorp H; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Coskuntürk M; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Oving IM; Department of Medical Oncology, Ziekenhuisgroep Twente, Almelo, The Netherlands.; van Ipenburg JA; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; van der Heijden AG; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Hofste T; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Weiss MM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Ligtenberg MJL; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Pathology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: Niven.mehra@radboudumc.nl.

Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101724904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2588-9311 (Electronic) Linking ISSN: 25889311 NLM ISO Abbreviation: Eur Urol Oncol Subsets: MEDLINE

Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Hofste LSM; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Kamping EJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Abdi Z; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Garms LM; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.; Klarenbeek BR; Department of Surgery, Radboud University Medical Center, Nijmegen, the Netherlands.; Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.

Publisher: Oxford University Press Country of Publication: England NLM ID: 9421549 Publication Model: Print Cited Medium: Internet ISSN: 1530-8561 (Electronic) Linking ISSN: 00099147 NLM ISO Abbreviation: Clin Chem Subsets: MEDLINE

Tolmeijer SH; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; Boerrigter E; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Sumiyoshi T; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Kwan EM; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Ng SWS; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Annala M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, Tampere, Finland.; Donnellan G; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Herberts C; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Benoist GE; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Hamberg P; Department of Medical Oncology, Franciscus Gasthuis & Vlietland, Rotterdam/Schiedam, the Netherlands.; Somford DM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.; van Oort IM; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Schalken JA; Department of Urology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Mehra N; Department of Medical Oncology, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands.; van Erp NP; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.; Wyatt AW; Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British of Columbia, Canada.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Hofste LSM; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Geerlings MJ; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; von Rhein D; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Tolmeijer SH; Department of Medical Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Weiss MM; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Gilissen C; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Hofste T; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Garms LM; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Janssen MJR; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Rütten H; Department of Radiation Oncology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Rosman C; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; van der Post RS; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Klarenbeek BR; Department of Surgery, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Ligtenberg MJL; Department of Human Genetics, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Koornstra RHT; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Medical Oncology, Rijnstate Hospital, 6815 AD Arnhem, The Netherlands.; de Groot JWB; Department of Medical Oncology, Isala Oncology Center, 8025 AB Zwolle, The Netherlands.; Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; van Rens DH; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Boers-Sonderen MJ; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

van Wilpe S; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Koornstra RHT; Department of Medical Oncology, Rijnstate Hospital, 6815 DA Arnhem, The Netherlands.; de Vries IJM; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Ligtenberg M; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, 6525 GA Nijmegen, The Netherlands.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE

Marijt KA; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands. K.A.Marijt@lumc.nl.; Sluijter M; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.; Blijleven L; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.; Tolmeijer SH; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.; Scheeren FA; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.; van der Burg SH; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.; van Hall T; Department of Medical Oncology, Oncode Institute, C7-P, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, the Netherlands.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Tolmeijer SH; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Boerrigter E; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Schalken JA; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; Geerlings MJ; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; van Oort IM; Department of Urology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands.; van Erp NP; Department of Pharmacy, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Ligtenberg MJL; Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pathology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101705370 Publication Model: Print Cited Medium: Internet ISSN: 2473-4284 (Electronic) Linking ISSN: 24734284 NLM ISO Abbreviation: JCO Precis Oncol Subsets: MEDLINE; PubMed not MEDLINE